These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26666932)

  • 1. Porin Loss Impacts the Host Inflammatory Response to Outer Membrane Vesicles of Klebsiella pneumoniae.
    Turner KL; Cahill BK; Dilello SK; Gutel D; Brunson DN; Albertí S; Ellis TN
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1360-9. PubMed ID: 26666932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porin loss in Klebsiella pneumoniae clinical isolates impacts production of virulence factors and survival within macrophages.
    Brunson DN; Maldosevic E; Velez A; Figgins E; Ellis TN
    Int J Med Microbiol; 2019; 309(3-4):213-224. PubMed ID: 31010630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.
    Sugawara E; Kojima S; Nikaido H
    J Bacteriol; 2016 Dec; 198(23):3200-3208. PubMed ID: 27645385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porin expression in clinical isolates of Klebsiella pneumoniae.
    Hernández-Allés S; Albertí S; Álvarez D; Doménech-Sánchez A; Martínez-Martínez L; Gil J; Tomás JM; Benedí VJ
    Microbiology (Reading); 1999 Mar; 145 ( Pt 3)():673-679. PubMed ID: 10217501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.
    Tsai YK; Fung CP; Lin JC; Chen JH; Chang FY; Chen TL; Siu LK
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1485-93. PubMed ID: 21282452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    Doumith M; Ellington MJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.
    Martínez-Martínez L; Pascual A; Conejo Mdel C; García I; Joyanes P; Doménech-Sánchez A; Benedí VJ
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3926-32. PubMed ID: 12435697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a novel outer membrane porin KpnO, regulated by PhoBR two-component system in Klebsiella pneumoniae NTUH-K2044.
    Srinivasan VB; Venkataramaiah M; Mondal A; Vaidyanathan V; Govil T; Rajamohan G
    PLoS One; 2012; 7(7):e41505. PubMed ID: 22848515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance.
    Doménech-Sánchez A; Hernández-Allés S; Martínez-Martínez L; Benedí VJ; Albertí S
    J Bacteriol; 1999 May; 181(9):2726-32. PubMed ID: 10217760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-betalactamase- producing Klebsiella pneumoniae.
    Shakib P; Ghafourian S; Zolfaghary MR; Hushmandfar R; Ranjbar R; Sadeghifard N
    Biologics; 2012; 6():1-4. PubMed ID: 22291461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
    Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
    J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different culture medium formulations induce variant protein expression patterns of outer membrane porins in Klebsiella pneumoniae.
    Chen JH; Lin JC; Chang JL; Tsai YK; Siu LK
    J Chemother; 2011 Feb; 23(1):9-12. PubMed ID: 21482487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen.
    Fajardo-Lubián A; Ben Zakour NL; Agyekum A; Qi Q; Iredell JR
    PLoS Pathog; 2019 Mar; 15(3):e1007218. PubMed ID: 30875398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum beta-lactamases and the permeability barrier.
    Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():82-9. PubMed ID: 18154531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.